Ten Year Mortality in Different Peripheral Arterial Disease Stages: A Population Based Observational Study on Outcome
- PMID: 29478910
- DOI: 10.1016/j.ejvs.2018.01.019
Ten Year Mortality in Different Peripheral Arterial Disease Stages: A Population Based Observational Study on Outcome
Abstract
Objective: The aim was to determine long-term mortality rates and the underlying cause of death for subjects with different peripheral arterial disease (PAD) stages in a population based setting.
Methods: A randomly selected population sample of 5080 subjects was enrolled in the study in 2004-2005. Participants completed health state questionnaires and underwent ankle brachial index (ABI) measurements for classification into PAD severity stages and reference subjects. A follow-up was conducted by the end of 2015 using data from Swedish governmental national registers for cause of death, which was then compared with PAD stage determined at baseline in 2005.
Results: The 10 year all cause mortality was 27% for reference cases, 56% for asymptomatic PAD (APAD), 63% for intermittent claudication (IC), and 75% for severe limb ischaemia (SLI). Among all PAD subjects, cardiovascular (CV) causes were the most common main cause of death (45%) and a CV event was present as either the main or one of the three most common contributing causes of death in 64% of the cases. The age adjusted hazard ratios for a main cause of death by a CV event were 1.9 (95% CI 1.5-2.3) for APAD, 2.6 (95% CI 2.1-3.4) for IC, and 3.5 (95% CI 2.3-5.2) for SLI.
Conclusion: PAD subjects, including the APAD subjects, are still at high risk of CV death. The mortality risks are more than doubled in symptomatic PAD patients compared with reference subjects and increase by severity of PAD stage. Awareness and improved risk reduction management of PAD are still warranted.
Keywords: Cardiovascular death; Mortality; Peripheral arterial disease.
Copyright © 2018 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.J Vasc Surg. 2016 Oct;64(4):1009-1017.e3. doi: 10.1016/j.jvs.2016.03.429. Epub 2016 May 18. J Vasc Surg. 2016. PMID: 27209402
-
Matrix metalloproteinase 10 is associated with disease severity and mortality in patients with peripheral arterial disease.J Vasc Surg. 2015 Feb;61(2):428-35. doi: 10.1016/j.jvs.2014.09.002. Epub 2014 Oct 23. J Vasc Surg. 2015. PMID: 25441671
-
Cardiovascular long-term outcome and prophylactic treatment patterns in peripheral arterial disease in a population-based cohort.Eur Heart J Qual Care Clin Outcomes. 2019 Oct 1;5(4):310-320. doi: 10.1093/ehjqcco/qcz037. Eur Heart J Qual Care Clin Outcomes. 2019. PMID: 31304962
-
Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication.J Vasc Surg. 2015 Mar;61(3 Suppl):2S-41S. doi: 10.1016/j.jvs.2014.12.009. Epub 2015 Jan 28. J Vasc Surg. 2015. PMID: 25638515 Review.
-
PORTRAIT (Patient-Centered Outcomes Related to Treatment Practices in Peripheral Arterial Disease: Investigating Trajectories): Overview of Design and Rationale of an International Prospective Peripheral Arterial Disease Study.Circ Cardiovasc Qual Outcomes. 2018 Feb;11(2):e003860. doi: 10.1161/CIRCOUTCOMES.117.003860. Circ Cardiovasc Qual Outcomes. 2018. PMID: 29440123 Review.
Cited by
-
Benefits of Integrating Technology into Home Exercise Therapy in Patients with Lower Extremity Peripheral Artery Disease.J Clin Med. 2023 Dec 12;12(24):7635. doi: 10.3390/jcm12247635. J Clin Med. 2023. PMID: 38137704 Free PMC article. Review.
-
Retinal and choriocapillaris perfusion are associated with ankle-brachial-pressure-index and Fontaine stage in peripheral arterial disease.Sci Rep. 2021 Jun 1;11(1):11458. doi: 10.1038/s41598-021-90900-5. Sci Rep. 2021. PMID: 34075122 Free PMC article.
-
Peripheral artery disease in patients with schizophrenia as compared to controls.BMC Cardiovasc Disord. 2023 Mar 8;23(1):126. doi: 10.1186/s12872-023-03143-9. BMC Cardiovasc Disord. 2023. PMID: 36890440 Free PMC article.
-
Primary results of the SAVAL randomized trial of a paclitaxel-eluting nitinol stent versus percutaneous transluminal angioplasty in infrapopliteal arteries.Vasc Med. 2023 Dec;28(6):571-580. doi: 10.1177/1358863X231199489. Epub 2023 Oct 16. Vasc Med. 2023. PMID: 37844137 Free PMC article. Clinical Trial.
-
Effects of a person-centred, nurse-led follow-up programme on adherence to prescribed medication among patients surgically treated for intermittent claudication: randomized clinical trial.Br J Surg. 2022 Aug 16;109(9):846-856. doi: 10.1093/bjs/znac241. Br J Surg. 2022. PMID: 35848783 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical